PRP Therapy for Plantar Fasciitis in Paterson, NJ

How Paterson is not Florida First Coast

Adult obesity in Paterson is 37.5% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 16.1% of adults in Paterson have diagnosed diabetes — 4.1 points above the U.S. 12% figure. New Jersey is outside CDC’s core Diabetes Belt list; use the PLACES city rate anyway. Hawk Medical is the distributor for prp plantar fasciitis, not a walk-in clinic.

Epidemiology is not a protocol

• Adult arthritis here is 20% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 28.6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in New Jersey.
• In a city under 250k, vendor noise is the operational problem: too many look-alike allograft flyers, too little chain-of-custody paperwork. Hawk Medical ships nationwide with HCT/P documentation; we do not invent a Paterson street address.
• New Jersey is outside CDC's historical Diabetes Belt core, but the national 12% diabetes figure still applies as a planning baseline until a clinic uses its own payer mix. Clinics asking for regenerative inventory still have to separate HCT/P 361 homologous-use products from unapproved “stem cell” claims (FDA 21 CFR 1271).

Uninsured mix and Medicare CTPs in the same building

JL reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Paterson is 16.1% or not. PLACES is planning data. The LCD is the claim.

How we’d stand this up in clinic